Distinguished in Rhizomelic Pseudopolyarthritis

Dr. Suzanne L. Gharib

Rheumatology
Charleston Area Medical Center Inc
4610 Maccorkle Ave Sw, Suite 301, 
South Charleston, WV 
Accepting New Patients
Offers Telehealth
Distinguished in Rhizomelic Pseudopolyarthritis
Charleston Area Medical Center Inc
4610 Maccorkle Ave Sw, Suite 301, 
South Charleston, WV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Suzanne Gharib is a Rheumatologist in South Charleston, West Virginia. Dr. Gharib is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Psoriatic Arthritis. Dr. Gharib is currently accepting new patients.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in WV
Hospital Affiliations
Charleston Area Medical Center
Camden Clark Medical Center
Mon Health Medical Center
Stonewall Jackson Memorial Hospital
Thomas Memorial Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

CHARLESTON AREA MEDICAL CENTER INC
4610 Maccorkle Ave Sw, Suite 301, South Charleston, WV 25309
Other Locations
STONEWALL JACKSON MEMORIAL HOSPITAL COMPANY
230 Hospital Plz, Weston, WV 26452

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Enrollment Status: Completed
Publish Date: August 17, 2017
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

1 Total Publications

The first non-radiographic axial spondyloarthrits with COVID-19.
The first non-radiographic axial spondyloarthrits with COVID-19.
Journal: Immunity, inflammation and disease
Published: February 26, 2021
Similar Doctors
Advanced in Rhizomelic Pseudopolyarthritis
Dr. Aesha Singh
Rheumatology
Advanced in Rhizomelic Pseudopolyarthritis
Dr. Aesha Singh
Rheumatology

University Physicians And Surgeons, Inc

1249 15th St, Suite 3000, 
Huntington, WV 
 (38.3 miles away)
304-691-1000
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Aesha Singh is a Rheumatologist in Huntington, West Virginia. Dr. Singh has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. Her top areas of expertise are Light Chain Deposition Disease (LCDD), MAGIC Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, and IgG4-Related Disease. Dr. Singh is currently accepting new patients.

Advanced in Rhizomelic Pseudopolyarthritis
Dr. Michael A. Istfan
Rheumatology
Advanced in Rhizomelic Pseudopolyarthritis
Dr. Michael A. Istfan
Rheumatology

Charleston Area Medical Center Inc

4610 Kanawha Ave Sw, 
South Charleston, WV 
 (0.1 miles away)
304-205-7992
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Istfan is a Rheumatologist in South Charleston, West Virginia. Dr. Istfan is rated as an Advanced provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Rheumatoid Arthritis (RA), Undifferentiated Connective Tissue Disease (UCTD), Polymyositis, and Palindromic Rheumatism. Dr. Istfan is currently accepting new patients.

Experienced in Rhizomelic Pseudopolyarthritis
Dr. Wassim S. Saikali
Rheumatology
Experienced in Rhizomelic Pseudopolyarthritis
Dr. Wassim S. Saikali
Rheumatology

Rheumatology And Pulmonary Clinic PLLC

421 Carriage Dr, 
Beckley, WV 
 (48.4 miles away)
304-256-0242
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Wassim Saikali is a Rheumatologist in Beckley, West Virginia. Dr. Saikali is rated as a Distinguished provider by MediFind in the treatment of Rhizomelic Pseudopolyarthritis. His top areas of expertise are Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, and Fibromyalgia. Dr. Saikali is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gharib's expertise for a condition
ConditionClose
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile